Searched for
ANTIMALARIAL DRUG
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Zydus Cadila receives orphan drug status from USFDA for its novel malaria drugDrug maker Cadila Healthcare (Zydus Cadila), on Thursday said its antimalarial drug ZY19489 (MMV253), currently in development together wit...
- COVID-19: Analysis reveals heart-related side effects of hydroxychloroquine, chloroquineIn the analysis of real-world data from the Food and Drug Administration Adverse Events Reporting System, a global database of post-marketi...
- Donald Trump says he is taking unproven drug hydroxychloroquine to ward off coronavirusThe drug has the potential to cause significant side effects in some patients and has not been shown to combat the new coronavirus. Trump s...
- Enough stock of hydroxychloroquine in India: Govt"There is enough stock of hydroxychloroquine in the country and we are tracking its demand, availability and production on a daily basis," ...
- Trump seeks Modi's help to release Hydroxychloroquine ordered by US to treat COVID-19 patientsIndia on April 4 banned the export of Hydroxychloroquine and its formulations with immediate effect.
- COVID-19: Orders for over 10 crore anti-malarial hydroxychloroquine tablets placed by CentreThe Indian Council of Medical Research (ICMR) has recommended the anti-malarial drug for those involved in the care of suspected or confirm...
- IIT Mandi researchers finds target protein for antimalarial drug against Zika VirusA team led by Rajanish Giri, assistant professor of Biotechnology at IIT Mandi, is working on this subject.
- Lincoln Pharma gets patent for anti-malarial drugThe company expects significant rise in the revenue from exports to Africa after the introduction of this injection in the African market.
- Zydus partners Swiss non-profit for malaria drug developmentUnder its latest tie-up, Zydus will lead the development of the compound, called MMV674253, while MMV will provide scientific expertise.
- Nutraplus starts production of Lumefantrine at Tarapur plantPharma firm Nutraplus India has started commercial production of anti-malarial drug Lumefantrine at its new plant at Tarapur in Maharashtra.
- Dr Datsons Labs to sell anti-malarial drugs in YemenDr Datsons Labs today said it has inked marketing and supply agreement with Yemen's Al-Mugdh Pharma to sell its anti-malarial drugs in Yemen
- Global travel may encourage anti-malaria drug resistanceThe authors also warned that an increase in international travel and migration might promote direct spread of drug resistance.
- Ghana drug regulator blacklists Indian firmIndian pharmaceutical firm Bliss GVS Pharma has been banned by Ghana's health watchdog from importing and distributing medicinal products t...
- Australian researchers find new drug to tackle malariaAustralian researchers said that a new drug that stops the malaria parasite from using vitamin B1 to multiply is now plausible.
- Drug-resistant malaria may spread, India warnedA new research has warned that drug-resistant malaria parasites on the border of Thailand & Myanmar may spread to India.
- Novartis cuts cost of malaria drug Coartem by 20%Swiss drug maker Novartis says it is lowering the public-sector price of its antimalarial drug Coartem by 20 per cent.
- WHO agency, Ranbaxy part ways from drug developmentWHO agency Medicines for Malaria Venture and Ranbaxy were involved in a four year-long joint development programme for an anti-malarial com...
Load More
